SophiA GENETICS Launches Global Consortium, SOPHIA UNITY, to Accelerate Cancer Research, Drug Development and Data-Driven Patient Care
New collective intelligence network to enable cutting-edge oncology research in support of precision medicine BOSTON and ROLES, Switzerland, May 30, 2024 /PRNewswire/ — SOPhiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced SOPhiA UNITY, a new data-driven consortium, created to accelerate cancer research globally. SOPHIA UNITY…